BIO.B
Bio-Rad Laboratories, Inc. Class B NYSE Listed Dec 30, 1899$299.45
Mkt Cap $8.3B
usd
Chart data loading — check back after 4:30 PM ET
P/E (TTM)
10.7x
EV/EBITDA
—
P/B
1.1x
Debt/Equity
0.2x
ROE
10.2%
P/FCF
—
RSI (14)
—
ATR (14)
—
Beta
—
50d MA
—
200d MA
—
Avg Volume
—
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
1000 ALFRED NOBEL DRIVE · HERCULES, CA 94547
Data updated apr 24, 2026 9:40pm
· Source: massive.com